Merck builds contract development and manufacturing facility for new viral vectors

The expansion project in Carlsbad, California, U.

Darmstadt, Germany, October 12, 2021 /PRNewswire/ - Leading technology company Merck today announced the opening of its second factory in Carlsbad, California, which greatly expands the company's global presence CDMO business footprint

Merck today announced the opening of its second facility in Carlsbad, California, which will more than double the company's existing capacity to support large-scale commercial and industrial manufacturing of viral gene therapies

Matthias Heinzel, member of Merck’s Executive Board and Chief Executive Officer of Life Sciences, said: “Currently, most gene therapies target rare diseases, but we urgently need to create such therapies in an efficient manner to benefit a larger patient population

This is the company's second facility in Carlsbad, California, serving customers in the cell and gene therapy field driven by the industry's rapid adoption of viral vector therapies

Heinzel added: "We continue to invest in solving cell and gene therapy development and manufacturing challenges, and cooperate with drug development companies to achieve industrialization, scale and accelerate the pace of providing treatment to patients

The establishment of the Carlsbad facility reinforces the company's ambition to accelerate growth by investing in "three major" businesses, including the life sciences process solutions business unit as a key driver

As one of the first CDMOs approved by the U.

About Merck

Merck is a leading technology company with businesses in healthcare, life sciences and electronics

Scientific exploration and responsible entrepreneurship have always been the key to Merck's technological progress

Source: Merck